Gritman Medical Center, Inc. v. Beckman Coulter, Inc.

District Court, D. Idaho·Decided October 4, 2023·No. 3:22-cv-00382·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF IDAHO

GRITMAN MEDICAL CENTER, INC., Case No. 3:22-cv-00382-BLW

Plaintiff, MEMORANDUM DECISION AND ORDER v.

ALLSCRIPTS HEALTHCARE SOLUTIONS INC. and BECKMAN COULTER, INC.,

Defendants.

INTRODUCTION Pending before the Court is Defendant Beckman Coulter, Inc.’s Rule 12(b)(6) Motion to Dismiss for Failure to State a Claim. (Dkt. 8). For the reasons explained below, the Court will grant the motion to dismiss but will allow the Plaintiff to amend its complaint. BACKGROUND1

1 At this early stage in the litigation, the Court must assume the truth of Gritman’s factual allegations. This does not mean, however, that the Court believes those allegations. Rather, the Court makes no determination whatsoever as to the truth or falsity of the factual assertions in the Complaint. Gritman Medical Center, Inc. (“Gritman”) is a hospital based in Latah County, Idaho. In 2016, Gritman purchased a UniCel DxC 600i Synchron Access

Clinical System machine (“DxC 600i” or the “machine”) from Beckman Coulter, Inc. (“Beckman”), a manufacturer of medical laboratory instruments and equipment.

1. The DxC 600i The DxC 600i is a laboratory machine developed by Beckman to detect prostate cancer. The machine analyzes a patient’s blood sample to detect the levels of prostate-specific antigen (PSA) secreted by the prostate gland. While threshold

levels of acceptable PSA in the bloodstream increase with age, higher levels are considered a clinical indicator of prostate cancer, and the FDA approved PSA testing as a cancer screening method in 1994. There are various enzymes and proteins that comprise total PSA (tPSA),

including free PSA (fPSA—not bound to a protein) and ProPSA (p2PSA—a proenzyme from which a propeptide is removed). Beckman developed a mathematical equation to synthesize the levels of fPSA, p2PSA, and tPSA in a

patient’s bloodstream into a “Prostate Health Index” (PHI) score that indicates whether the patient has, or is at risk for, prostate cancer. The PHI was approved by the FDA in 2012 as a cancer screening method for men with tPSA levels within a certain range. The DxC 600i is designed to detect the PSA levels in the patient’s blood

sample, run the equation, and calculate the PHI score. The PHI score is then transmitted to the hospital or clinic’s electronic health records (“EHR”) management system.2 In addition, it appears from the allegations in the Complaint

that the machine does not automatically calculate a PHI score for every patient, but only those with certain overall PSA values. When such a PSA value is detected, the DxC 600i will automatically “reflex” and check the fPSA and, if necessary, p2PSA levels, and then calculate a PHI.

2. The Transaction and Machine Setup Sometime in 2016, Gritman purchased the DxC 600i from Beckman. A Beckman technician assisted in the installation, configuration, and testing of the machine. During the installation process, a Gritman employee informed the

Beckman technician that the PHI was not printing on the machine-generated

2 EHR systems are used by hospitals to track patients’ lab and imaging results and are used by healthcare providers to chart patient records. EHR systems generally contain the entirety of a patient’s health record from that healthcare facility. In 2016, when Gritman acquired the DxC 600i, McKesson Corporation, a third party, operated the hospital’s EHR management system. Gritman’s EHR system is currently operated by AllScripts, which at the time of the filing of the Complaint, was owned by Paragon Direct Services. AllScripts is now known as Veradigm LLC. In this Order, the Court will refer to the EHR company as “AllScripts.” report. The Beckman technician nevertheless assured the Gritman employee that each equation value and subsequent PHI result was being correctly transmitted to

Gritman’s EHR system. The Complaint does not indicate whether Beckman offered any kind of warranty for the machine. Nor does it state precisely when the purchase or

installation occurred. 3. The Alleged Machine Malfunction In March 2020, a patient contacted and informed Gritman that the PHI score on the labs he had received from Gritman was incorrect. On March 25, 2020,

Gritman began investigating the source of the error. Gritman contacted Beckman, but Beckman was unable to determine where an error may have occurred and could provide no solution. Gritman then contacted AllScripts, the hospital’s EHR provider and co-defendant in this case, which proposed two solutions.

Each solution involved altering the way the PHI equation was written in “the system.” Compl. ¶ 47, Dkt. 1-1. The first suggestion was to change a fraction to a decimal, and the second involved inserting an extra set of parentheses around the

entire equation. Both solutions were offered as a way to make the equation translate to the EHR system correctly. However, it is unclear from Complaint whether AllScripts’ proposed solutions involved making adjustments within its own system or to the DxC 600i itself. Gritman then notified patients that the PHI scores they were provided were

incorrect and paid medical expenses for some of those patients. It now seeks to recoup those expenses. 4. Procedural History On March 15, 2022, Gritman filed a complaint in Idaho state court against

Beckman and Allscripts asserting four claims: (1) breach of contract; (2) products liability and failure to warn; (3) equitable or contractual indemnification; and (4) negligence. On September 7, 2022, Beckman timely filed a notice to remove the

case to federal court based on diversity jurisdiction. (Dkt. 1). Gritman moved to remand the case to state court, Dkt. 12, but the Court denied that motion (Dkt. 30). Beckman subsequently filed the present Rule 12(b)(6) Motion to Dismiss for Failure to State a Claim upon which relief may be granted. The motion is fully

briefed and before the Court. As explained below, the Court will grant the motion to dismiss, but will allow Gritman to file an amended complaint in accordance with this Order.

LEGAL STANDARD Federal Rule of Civil Procedure 8(a)(2) requires only “’a short and plain statement of the claim showing that the pleader is entitled to relief,’ in order to ‘give the defendant fair notice of what the . . . claim is and the grounds upon which it rests.’” Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007) (quoting

Conley v. Gibson, 355 U.S. 41, 47 (1957)). While a complaint “does not need detailed factual allegations,” it must set forth “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not

do.” Twombly, 550 U.S. at 555. To survive a Rule 12(b)(6) motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to “state a claim to relief that is plausible on its face.” Id. at 570. A claim is plausible when the plaintiff pleads facts upon which the Court can

reasonably infer that the defendant may be liable for the misconduct alleged. Id. at 556. The plausibility standard is not akin to a “probability requirement,” but it asks for more than a sheer possibility that a defendant has acted unlawfully. Id. Where a

complaint pleads facts that are “merely consistent with” a defendant's liability, it “stops short of the line between possibility and plausibility of ‘entitlement to relief.’” Id. at 557 (internal citation omitted). A case should be dismissed with leave to amend unless it is doubtless that

Free access — add to your briefcase to read the full text and ask questions with AI

Gritman Medical Center, Inc. v. Beckman Coulter, Inc., (D. Idaho 2023).

Gritman Medical Center, Inc. v. Beckman Coulter, Inc. (Gritman Medical Center, Inc. v. Beckman Coulter, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Nation v. State, Dept. of Correction
158 P.3d 953 (Idaho Supreme Court, 2007)
Idaho Wool Growers v. State of Idaho Fish & Game
302 P.3d 341 (Idaho Supreme Court, 2012)
Tuttle v. Sudenga Industries, Inc.
868 P.2d 473 (Idaho Supreme Court, 1994)
Puckett v. Oakfabco, Inc.
979 P.2d 1174 (Idaho Supreme Court, 1999)
May Trucking Co. v. International Harvester Co.
543 P.2d 1159 (Idaho Supreme Court, 1975)
Duffin v. Idaho Crop Improvement Ass'n
895 P.2d 1195 (Idaho Supreme Court, 1995)
Chenery v. Agri-Lines Corp.
766 P.2d 751 (Idaho Supreme Court, 1988)
Sliman v. Aluminum Co. of America
731 P.2d 1267 (Idaho Supreme Court, 1986)
Harris v. Amgen, Inc.
573 F.3d 728 (Ninth Circuit, 2009)
Edged in Stone, Inc. v. Northwest Power Systems, LLC
321 P.3d 726 (Idaho Supreme Court, 2014)
Massey Ex Rel. Massey v. Conagra Foods, Inc.
328 P.3d 456 (Idaho Supreme Court, 2014)
Beitzel v. City of Coeur D'Alene
827 P.2d 1160 (Idaho Supreme Court, 1992)